L'Oréal (OR) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
19 Jan, 2026Executive summary
Achieved 6% like-for-like sales growth for the first nine months of 2024, reaching €32.4 billion, with growth in all divisions and regions except North Asia, despite external headwinds, especially in China and travel retail.
Growth was balanced between value and volume, with robust trends in Europe, North America, and emerging markets, and continued share gains in three out of four divisions.
Fragrance and haircare segments showed strong growth, while makeup is recovering, supported by new product launches.
Online sales outpaced offline, especially in emerging markets.
Acquisition of a 10% stake in Galderma and recognition for diversity and innovation were notable achievements.
Financial highlights
Group sales for the first nine months: €32.41 billion, up 6.0% like-for-like and reported.
Growth at constant exchange rates was 8.1%; currency fluctuations had a -2.1% impact.
Fragrance and haircare delivered double-digit growth year-to-date; makeup is gradually recovering.
Dermatological Beauty division saw a slowdown in Q3, mainly due to U.S. market deceleration and sun care inventory effects.
Exceptional French tax for 2024 estimated at €250 million.
Outlook and guidance
Q4 expected to be consistent with Q3, with holiday season strength in fragrances but continued macro uncertainty, especially in China.
Confident in outperforming the market for full-year 2024 and delivering growth in sales and operating profits.
2025 global beauty market expected to return to pre-COVID growth rates of 4–5%.
Preparing a robust Beauty Stimulus Plan for 2025, with increased innovation and product launches across all categories.
Latest events from L'Oréal
- Record sales, innovation, and U.S. market leadership drive strong growth and digital transformation.OR
Consumer Analyst Group of New York Conference (CAGNY) 202620 Feb 2026 - Sales up 4.0% LFL to €44.1bn, record margins, and digital growth drive strong outlook.OR
Q4 202513 Feb 2026 - Record sales and margins in 2024, with broad-based growth and strong 2025 outlook.OR
Q4 20243 Feb 2026 - H1 2024 sales and profit rose, led by Dermatological Beauty and double-digit regional growth.OR
H1 20242 Feb 2026 - A 10% stake enables strategic access to the fast-growing injectable aesthetics market.OR
M&A Announcement2 Feb 2026 - Outperformed the market in 2024, leveraging innovation, AI, and global expansion for future growth.OR
Consumer Analyst Group of New York Conference (CAGNY) 20257 Jan 2026 - Accelerating U.S. growth, market leadership, and digital innovation drive future gains.OR
CMD 20254 Dec 2025 - Luxury beauty outpaces the market with innovation, global reach, and strong brand portfolio.OR
Investor Update2 Dec 2025 - Digital, innovation, and agile strategy drive robust, accelerating growth across global beauty markets.OR
Fireside Chat2 Dec 2025